At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
The countdown to the new year is nearly upon us, but no need to count down to the last...
In November, the AACR’s journal editors highlighted studies on sucralose limiting immunotherapy, benefits of caloric restriction, and more.
In October 2025, AACR's journals editors highlighted studies on the anticancer function of an Alzheimer’s-related protein, small-molecule-drug conjugates, and...
This year, Party with a Purpose honors melanoma researchers Lynn Schuchter and Alexander Huang, and humanitarian honoree Patricia Wellenbach.
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
Cancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives...
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...